We also explore therapeutic strategies targeting NOX-NOS interactions, including selective NOX inhibitors, NOS modulators, and redox homeostasis regulators, providing new insights into redox regulation and the management of metabolic neurodegenerative diseases. The gene discussed is NOS2; the disease is neurodegenerative disease.